One World Products (OWPC) 10-Q 14 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 10, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	000-56151
Entity Registrant Name	ONE WORLD PRODUCTS, INC.
Entity Central Index Key	0001622244
Entity Tax Identification Number	61-1744826
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	6605 Grand Montecito Pkwy
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89149
City Area Code	(800)
Local Phone Number	605-3210
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		105,890,570

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 81,630	$ 726
Accounts receivable	179
Inventory	16,633
Prepaid expenses	16,741	13,156
Total current assets	115,183	13,882
Security deposits	85,000	85,000
Licenses	75,000
Total Assets	275,183	98,882
Current liabilities:
Accounts payable	574,967	528,645
Accrued expenses	1,055,535	939,368
Dividends payable	241,649	196,734
Total current liabilities	3,269,683	3,872,111
Total Liabilities	5,359,803	3,872,111
Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value, 9,200,000 shares authorized; no shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively
Common stock, $0.001 par value, 1,000,000,000 shares authorized; 105,890,570 and 79,827,618 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	105,891	79,828
Additional paid-in capital	20,315,010	18,414,456
Subscriptions payable		45,000
Accumulated other comprehensive income		42,328
Accumulated (deficit)	(30,230,366)	(26,929,686)
Total Stockholders’ Equity (Deficit)	(9,809,465)	(8,348,074)
Total Liabilities and Stockholders’ Equity (Deficit)	275,183	98,882
Series A Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	1,147,330	997,330
Series B Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	3,577,515	3,577,515
Related Party [Member]
Current liabilities:
Convertible note payable, related party, current maturities		750,000
Notes payable		1,146,500
Notes payable, related parties, long-term portion, net of $3,861 of debt discounts at September 30, 2024	2,090,120
Nonrelated Party [Member]
Current liabilities:
Notes payable	1,397,532	310,864
Notes payable, related parties, long-term portion, net of $3,861 of debt discounts at September 30, 2024

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Debt discount current	$ 237,468	$ 24,136
Debt discount non current	$ 3,861
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	9,200,000	9,200,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	105,890,570	79,827,618
Common stock, shares outstanding	105,890,570	79,827,618
Series A Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	500,000	500,000
Temporary equity shares issued	114,733	114,733
Temporary equity, shares outstanding	114,733	114,733
Preferred stock, shares authorized	10,000,000
Series B Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	600,000	600,000
Temporary equity shares issued	238,501	238,501
Temporary equity, shares outstanding	238,501	238,501

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues	$ 1,517	$ 5,906	$ 3,053	$ 8,082
Cost of goods sold	310	767	588	1,866
Gross loss	1,207	5,139	2,465	6,216
Operating expenses:
General and administrative	203,242	142,464	552,874	907,595
Professional fees	169,596	236,139	971,934	413,651
Depreciation expense		9,274		25,578
Total operating expenses	372,838	387,877	1,524,808	1,346,824
Operating loss	(371,631)	(382,738)	(1,522,343)	(1,340,608)
Other income (expense):
Gain (loss) on early extinguishment of debt			(724,086)	4,397
Loss on deconsolidation of foreign subsidiaries	(22,359)		(242,631)
Interest income		3		6
Interest expense	(340,609)	(67,571)	(811,620)	(177,169)
Total other expense	(362,968)	(67,568)	(1,778,337)	(172,766)
Net loss	(734,599)	(450,306)	(3,300,680)	(1,513,374)
Other comprehensive loss:
Gain (loss) on foreign currency translation		(32,831)	(42,328)	145,370
Net other comprehensive loss	(734,599)	(483,137)	(3,343,008)	(1,368,004)
Series A convertible preferred stock declared ($0.60 per share)	(15,083)	(15,083)	(44,915)	(43,808)
Net loss attributable to common shareholders	$ (749,682)	$ (498,220)	$ (3,387,923)	$ (1,411,812)
Weighted average number of common shares outstanding - basic	113,618,305	74,958,373	104,404,946	71,436,129
Weighted average number of common shares outstanding - diluted	113,618,305	74,958,373	104,404,946	71,436,129
Net loss per share - basic	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.02)
Net loss per share - diluted	(0.01)	(0.01)	(0.03)	(0.02)
Dividends declared per share of common stock	$ 0	$ 0	$ 0	$ 0

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Preferred stock dividends per share	$ 0.60	$ 0.60	$ 0.60	$ 0.60
Series A Convertible Preferred Stock [Member]
Preferred stock dividends per share	$ 0.60	$ 0.60	$ 0.60	$ 0.60

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscriptions Payable [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 702,330	$ 4,082,520	$ 67,203	$ 17,123,603		$ (50,699)	$ (22,976,365)	$ (5,836,258)
Balance, shares at Dec. 31, 2022	70,233	272,168	67,202,907
Common stock issued for services			$ 2,500	171,350				173,850
Common stock issued for services, shares			2,500,000
Amortization of common stock options issued for services				121,052				121,052
Series A convertible preferred stock dividend declared				(43,808)				(43,808)
Net loss							(1,513,374)	(1,513,374)
Series A Convertible Preferred Stock sold for cash	$ 250,000
Series A Convertible Preferred Stock sold for cash, shares	25,000
Series B preferred stock conversions		$ (355,005)	$ 2,366	352,639				355,005
Series B preferred stock conversions, shares		(23,667)	2,366,700
Gain on foreign currency translation						145,370		145,370
Commitment shares issued pursuant to promissory note			$ 1,667	40,508				42,175
Commitment shares issued pursuant to promissory note, shares			1,666,667
Series A Convertible Preferred Stock issued for services	$ 45,000				45,000			45,000
Series A Convertible Preferred Stock issued for services, shares	4,500
Common stock sold for cash			$ 3,000	297,000				300,000
Common stock sold for cash, shares			3,000,000
Balance at Sep. 30, 2023	$ 997,330	$ 3,727,515	$ 76,736	18,062,344	45,000	94,671	(24,489,739)	(6,210,988)
Balance, shares at Sep. 30, 2023	99,733	248,501	76,736,274
Balance at Jun. 30, 2023	$ 997,330	$ 4,082,520	$ 73,370	17,594,074		127,502	(24,039,433)	(6,244,487)
Balance, shares at Jun. 30, 2023	99,733	272,168	73,369,574
Common stock issued for services			$ 1,000	83,000				84,000
Common stock issued for services, shares			1,000,000
Amortization of common stock options issued for services				47,714				47,714
Series A convertible preferred stock dividend declared				(15,083)				(15,083)
Net loss							(450,306)	(450,306)
Series A Convertible Preferred Stock sold for cash					45,000			45,000
Series A Convertible Preferred Stock sold for cash, shares
Series B preferred stock conversions		$ (355,005)	$ 2,366	352,639				355,005
Series B preferred stock conversions, shares		(23,667)	2,366,700
Gain on foreign currency translation						(32,831)		(32,831)
Balance at Sep. 30, 2023	$ 997,330	$ 3,727,515	$ 76,736	18,062,344	45,000	94,671	(24,489,739)	(6,210,988)
Balance, shares at Sep. 30, 2023	99,733	248,501	76,736,274
Balance at Dec. 31, 2023	$ 997,330	$ 3,577,515	$ 79,828	18,414,456	45,000	42,328	(26,929,686)	(8,348,074)
Balance, shares at Dec. 31, 2023	99,733	238,501	79,827,618
Series A Convertible Preferred Stock sold for cash, Director	$ 150,000
Series A Convertible Preferred Stock sold for cash, shares	15,000
Cancellation of subscriptions payable				45,000	(45,000)
Common stock issued for services			$ 10,342	614,383				624,725
Common stock issued for services, shares			10,341,952
Amended warrants				51,008				51,008
Amortization of common stock options issued for services				11,597				11,597
Series A convertible preferred stock dividend declared				(44,915)				(44,915)
Net loss							(3,300,680)	(3,300,680)
Gain on foreign currency translation						(42,328)		(42,328)
Common stock issued pursuant to debt modifications			$ 10,971	713,115				724,086
Common stock issued pursuant to debt modifications, shares			10,971,000
Commitment shares issued pursuant to promissory note			$ 4,750	158,728				163,478
Commitment shares issued pursuant to promissory note, shares			4,750,000
Relative fair value of warrants issued for loan commitment				351,638				351,638
Balance at Sep. 30, 2024	$ 1,147,330	$ 3,577,515	$ 105,891	20,315,010			(30,230,366)	(9,809,465)
Balance, shares at Sep. 30, 2024	114,733	238,501	105,890,570
Balance at Jun. 30, 2024	$ 997,330	$ 3,577,515	$ 104,330	20,175,359	57,473		(29,495,767)	(9,158,605)
Balance, shares at Jun. 30, 2024	99,733	238,501	104,329,919
Series A Convertible Preferred Stock sold for cash, Director	$ 150,000
Series A Convertible Preferred Stock sold for cash, shares	15,000
Cancellation of subscriptions payable				45,000	(45,000)
Common stock issued for services			$ 1,561	54,833	(12,473)			43,921
Common stock issued for services, shares			1,560,651
Amended warrants				51,008				51,008
Amortization of common stock options issued for services				3,893				3,893
Series A convertible preferred stock dividend declared				(15,083)				(15,083)
Net loss							(734,599)	(734,599)
Balance at Sep. 30, 2024	$ 1,147,330	$ 3,577,515	$ 105,891	$ 20,315,010			$ (30,230,366)	$ (9,809,465)
Balance, shares at Sep. 30, 2024	114,733	238,501	105,890,570

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Preferred stock dividends per share	$ 0.60	$ 0.60	$ 0.60	$ 0.60

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (3,300,680)	$ (1,513,374)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense		25,578
(Gain) loss on early extinguishment of debt	724,086	(4,397)
Amortization of debt discounts	529,423	26,233
Series A preferred stock issued for services		90,000
Common stock issued for services	624,725	173,850
Stock options issued for services	11,597	121,052
Amended warrants	51,008
Decrease (increase) in assets:
Accounts receivable	(179)	(133)
Inventory	(16,633)	(258,583)
Other current assets	(3,585)	20,219
Other assets		(33,666)
Right-of-use assets		34,391
Increase (decrease) in liabilities:
Accounts payable	46,322	17,774
Accrued expenses	323,648	290,021
Deferred revenues		(263)
Lease liability		(31,940)
Net cash used in operating activities	(1,010,268)	(1,043,238)
Cash flows from investing activities
Purchase of fixed assets		(5,046)
Purchase of Pétalo Pharmaceutical, SAS	(75,000)
Net cash used in investing activities	(75,000)	(5,046)
Cash flows from financing activities
Proceeds from notes payable, related parties	347,000	62,000
Repayments of notes payable, related parties	(357,000)
Proceeds from notes payable	1,728,500	262,500
Repayments of notes payable	(660,000)
Proceeds from sale of preferred and common stock	150,000	550,000
Net cash provided by financing activities	1,208,500	874,500
Effect of exchange rate changes on cash	(42,328)	172,920
Net increase in cash	80,904	(864)
Cash - beginning	726	11,016
Cash - ending	81,630	10,152
Supplemental disclosures:
Interest paid	147,996	40,693
Income taxes paid
Non-cash investing and financing transactions:
Dividends payable	44,915	43,808
Deposit on equipment settled with note payable		35,000
Value of debt discounts attributable to commitment shares to related parties	9,839
Value of debt discounts attributable to commitment shares	153,639	42,175
Value of debt discounts attributable to commitment warrants	$ 351,638

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Note 1 – Nature of Business and Significant Accounting Policies Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, the Company entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., a wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian Simplified Shares Company (“OWP SAS”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP SAS) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP SAS. OWP SAS is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). The Company had intended to be a producer of and/or source raw and processed cannabis and hemp plant ingredients for both medical and industrial uses across the globe. The Company received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, the Company was one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, the Company owns approximately 30 acres and has a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. During the first quarter of 2022, the Company made payments of approximately $ 1,400,000 On December 22, 2023, OWP SAS, f iled for protection under Colombian Law 1116 of 2006, which is the primary legislation governing business insolvency proceedings (restructuring and liquidation) (“Reorganization Proceedings”) in Colombia. In connection with the Reorganization Proceedings, OWP SAS paused production and sales of our cannabis operations in Colombia until the Court provided the Company with a plan of reorganization, at which time the Company intended to resume operations and satisfy its obligations in Colombia in accordance with the court’s plan, however, the Company now intends to have the Court liquidate its assets and pay its creditors out of the proceeds of the liquidation. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) In accordance with ASC 810-10-15, the Company has deconsolidated its foreign subsidiaries to include the petitioning entity, OWP SAS, as well as the Company’s non-operating shell entities, Agrobase, S.A.S. and Hope Colombia, S.A.S., given the lack of independently identifiable operations. The deconsolidation resulted in a loss on deconsolidation of foreign subsidiaries in the amount of $ 242,631 1,564,823 During March of 2024, the Company, through OWP Ventures, began to sell a CBD based product in the United States, called Pro-11. During the fourth quarter of 2024, the Company began to redesign the packaging and engaged a sales representative to focus greater resources on bringing this product to market. On May 15, 2024, OWP Ventures, Inc., acquired Pétalo Pharmaceutical, S.A.S. (“Pétalo”), a Company located in Colombia and legally constituted as a simplified stock company that owns licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes from the free trade zone in Colombia. Pétalo had no operations, other than obtaining four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export from the free trade zone. The acquisition was accounted for as an asset purchase, and the $ 75,000 During 2024, the Company has also been developing industrial hemp solutions for the automotive market. The Company intends to focus increased efforts on research and development in this area to help the automotive industry meet its goals of achieving carbon neutral manufacturing using renewable material solutions. In October of 2024, the Company, in collaboration with partners in the automotive industry, developed hemp-based molded containers for automotive part packaging applications and received an initial order for 1,400 units of these reusable totes, designed to move and protect automotive parts through the supply chain. Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. The unaudited condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Such adjustments are of a normal, recurring nature. The Condensed Consolidated Financial Statements, and the accompanying notes, are prepared in accordance with GAAP and do not contain certain information included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The interim Condensed Consolidated Financial Statements should be read in conjunction with that Annual Report on Form 10-K. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2024: Schedule of Common Control and Ownership Interest Jurisdiction of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary Pétalo Pharmaceutical, S.A.S. (3) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on May 15, 2024, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings. Foreign Currency Translation The functional currency of the Company is Colombian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar (USD) throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods. Comprehensive Income The Company has adopted the Financial Accounting Standards Boards (“FASB”) Accounting Standards Codification (“ASC”) 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820 – Fair Value Measurement and Disclosures (ASC 820). Under ASC 820-10-05, the FASB establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses reported on the balance sheets are estimated by management to approximate fair value primarily due to the short-term nature of the instruments. Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 no Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s revenues in the current period consisted of the sale of our CBD rub, and in the prior period revenues consisted entirely of the sale of seeds. The sale of seeds included multi-element arrangements whereby the Company collected 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company had a right of first refusal to purchase products resulting from the harvest. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance. Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share. Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In December 2023 , FASB issued “Income Taxes (Topic ): Improvements to Income Tax Disclosures,” , There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2 – Going Concern As shown in the accompanying condensed consolidated financial statements as of September 30, 2024, our balance of cash on hand was $ 81,630 3,154,500 30,230,366 In the event sales do not materialize at the expected rates, management would seek additional financing and would attempt to conserve cash by further reducing expenses. There can be no assurance that we will be successful in achieving these objectives; therefore, without sufficient financing it would be unlikely for the Company to continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. The condensed consolidated financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. Our ability to scale production and distribution capabilities and further increase the value of our brands, is largely dependent on our success in raising additional capital. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Deconsolidation of Foreign Subs

Deconsolidation of Foreign Subsidiaries	9 Months Ended
	Sep. 30, 2024
Deconsolidation Of Foreign Subsidiaries
Deconsolidation of Foreign Subsidiaries	Note 3 – Deconsolidation of Foreign Subsidiaries On December 22, 2023, our wholly-owned subsidiary, One World Products, S.A.S., a Colombian Simplified Shares Company, f iled for protection under Colombian Law 1116 of 2006, which is the primary legislation governing business insolvency proceedings (restructuring and liquidation) (“Reorganization Proceedings”) in Colombia. 1.2 242,631 1,564,823 Schedule of Deconsolidated Balance Sheets and Statement of Operations and Comprehensive Loss of Foreign Subsidiaries FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, December 31, 2024 2023 Assets Current assets: Cash $ 8,472 $ 1,660 Inventory 37,393 45,791 Other current assets 15,971 2,687 Total current assets 61,836 50,138 Other assets 207,928 226,542 Fixed assets, net 2,306,501 2,346,281 Total Assets $ 2,576,265 $ 2,622,961 Liabilities and Stockholders’ Equity (Deficit) Current liabilities: Accounts payable $ 331,121 $ 392,403 Accrued expenses 481,277 482,587 Notes payable 168,099 183,148 Intercompany liabilities owed to OWP Ventures, Inc. 7,737,202 7,348,034 Total current liabilities 8,717,699 8,406,172 Stockholders’ Equity (Deficit): Accumulated other comprehensive income 62,311 - Accumulated (deficit) (6,203,745 ) (5,783,211 ) Total Stockholders’ Equity (Deficit) (6,141,434 ) (5,783,211 ) Total Liabilities and Stockholders’ Equity (Deficit) $ 2,576,265 $ 2,622,961 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS For the Three For the Nine Months Ended Months Ended September 30, September 30, 2024 2024 Revenues $ - $ - Cost of goods sold - - Gross profit - - Operating expenses: General and administrative 67,115 208,062 Professional fees 12,121 44,250 Depreciation expense 13,260 39,780 Total operating expenses 92,496 292,092 Operating loss (92,496 ) (292,092 ) Other income (expense): Interest expense (48,329 ) (128,442 ) Total other expense (48,329 ) (128,442 ) Net loss $ (140,825 ) $ (420,534 ) Other comprehensive loss: Gain on foreign currency translation $ 3,625 $ 62,311 Net loss $ (137,200 ) $ (358,223 ) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS For the Nine Months Ended September 30, 2024 Cash flows from operating activities Net loss $ (420,534 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization expense 39,780 Decrease (increase) in assets: Inventory 8,398 Other current assets (13,284 ) Other assets 18,614 Increase (decrease) in liabilities: Accounts payable (61,282 ) Accrued expenses (16,359 ) Accrued interest on intercompany loans 104,210 Net cash used in operating activities (340,457 ) Cash flows from financing activities Proceeds received from intercompany loan 284,958 Net cash provided by financing activities 284,958 Effect of exchange rate changes on cash 62,311 Net increase (decrease) in cash 6,812 Cash - beginning 1,660 Cash - ending $ 8,472 Supplemental disclosures: Interest paid $ - Income taxes paid $ -

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 – Related Party Transactions Series A Preferred Stock Sale to Director On July 25, 2024, the Company received proceeds of $ 150,000 15,000 15,000 1,500,000 0.25 152 0.0272 40,873 Related Party Debt Repayments On July 26, 2024, the Company partially repaid $ 150,000 337,000 On April 22, 2024, the Company repaid an aggregate total of $ 257,446 207,000 50,446 Common Stock Issued as Consideration for Related Party Debt Modifications On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., agreed to issue shares of common stock to officers and directors in consideration for extending the maturity dates and terms of previously received debt financing, as listed below. The aggregate fair value of the common stock was $ 724,086 March 1, 2027 10 7 Schedule of Related Party Debt Modification Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Common Stock Issued for Services, Related Parties On September 25, 2024, the Company issued 600,000 The fair value of the 15,000 On July 1, 2024, the Company issued 250,000 The fair value of the 11,250 On March 15, 2024, the Company issued shares of common stock to officers and directors for services provided, as listed below. The aggregate fair value of the common stock was $ 429,000 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2024
Investments, All Other Investments [Abstract]
Fair Value of Financial Instruments	Note 5 – Fair Value of Financial Instruments Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value. The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheet as of September 30, 2024 and December 31, 2023, respectively: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at September 30, 2024 Level 1 Level 2 Level 3 Assets Cash $ 81,630 $ - $ - Total assets 81,630 - - Liabilities Convertible notes payable, related party - - - Notes payable, related parties, net of $ 7,153 - 2,090,120 - Notes payable, net of $ 434,289 - 1,397,532 - Total liabilities - (3,487,652 ) - Fair Value, Net Asset (Liability) $ 81,630 $ (3,487,652 ) $ - Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2023 Level 1 Level 2 Level 3 Assets Cash $ 726 $ - $ - Total assets 726 - - Liabilities Convertible notes payable, related party - 750,000 - Notes payable, related parties - 1,146,500 - Notes payable, net of $ 24,136 - 310,864 - Total liabilities - (2,207,364 ) - Fair Value, Net Asset (Liability) $ 726 $ (2,207,364 ) $ - There were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the nine months ended September 30, 2024 or the year ended December 31, 2023. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Inventory

Inventory	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Inventory	Note 6 – Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our CBD products consist entirely of finished goods. Inventory was $ 16,633 0

Security Deposits

Security Deposits	9 Months Ended
	Sep. 30, 2024
Security Deposits	Note 7 – Security Deposits Security deposits consisted of refundable deposits on equipment purchases in the amount of $ 85,000

Licenses

Licenses	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Licenses	Note 8 – Licenses On May 15, 2024, OWP Ventures, Inc., acquired Pétalo Pharmaceutical, S.A.S. (“Pétalo”), a Company located in Colombia and legally constituted as a simplified stock company that owns licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes from the free trade zone in Colombia. Pétalo had no operations, other than obtaining four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export from the free trade zone. The Company intends to use these licenses to establish an export business within the free trade zone. The acquisition was accounted for as an asset purchase, and the $ 75,000

Accrued Expenses

Accrued Expenses	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Accrued Expenses	Note 9 – Accrued Expenses Accrued expenses consisted of the following at September 30, 2024 and December 31, 2023, respectively: Schedule of Accrued Expenses September 30, December 31, 2024 2023 Accrued compensation $ 905,872 $ 665,417 Accrued interest 149,663 273,951 Accrued expenses $ 1,055,535 $ 939,368 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Convertible Note Payable, Relat

Convertible Note Payable, Related Party	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Convertible Note Payable, Related Party	Note 10 – Convertible Note Payable, Related Party Convertible note payable, related party consists of the following at September 30, 2024 and December 31, 2023, respectively: Schedule of Convertible Note Payable Related Party September 30, December 31, 2024 2023 On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 September 16, 2024 8 15 750,000 90,740 March 1, 2027 7 9,017,000 595,122 $ - $ 750,000 Total convertible note payable, related party - 750,000 Less: current maturities - - Convertible note payable, related party, long-term portion $ - $ 750,000 The Company recorded interest expense pursuant to the stated interest rates on the convertible note, related party in the amount of $ 15,124 44,877

Notes Payable, Related Parties

Notes Payable, Related Parties	9 Months Ended
	Sep. 30, 2024
Notes Payable Related Parties
Notes Payable, Related Parties	Note 11 – Notes Payable, Related Parties Notes payable, related parties, consists of the following at September 30, 2024 and December 31, 2023, respectively: Schedule of Notes Payable Related Party September 30, December 31, 2024 2023 On March 19, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 March 1, 2027 10 $ 50,000 $ - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 26,116 March 1, 2027 10 25,000 1,116 26,116 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 1,803,398 March 1, 2027 7 840,740 750,000 90,740 962,658 850,000 112,658 1,803,398 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 337,000 March 1, 2027 10 337,000 150,000 187,000 - ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 27,467 March 1, 2027 10 24,500 2,967 27,467 - On March 12, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 10 101,123 100,000 1,123 - - On March 1, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 March 1, 2025 8 March 1, 2027 - - On February 26, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 27,000 10 27,414 27,000 414 - - On January 29, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 January 29, 2025 8 March 1, 2027 - - On January 11, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,279 10,000 279 - - On January 8, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,288 10,000 288 - - On November 28, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 60,000 10 62,400 60,000 2,400 - 60,000 On October 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 25,000 10 March 1, 2027 - 25,000 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On September 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 52,000 10 March 1, 2027 2,650 - 52,000 On August 31, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,000 6 March 1, 2027 130 - 4,000 On August 14, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 6,000 6 March 1, 2027 211 - 6,000 On August 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 6 March 1, 2027 4,833 - 50,000 On August 2, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,500 6 March 1, 2027 - 4,500 On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 8 March 1, 2027 - 100,000 On July 7, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 5,000 6 March 1, 2027 507 - 5,000 On June 3, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 20,000 6 2,236 - 20,000 On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 8 March 1, 2027 - 400,000 On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 - 200,000 On December 29, 2021, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 35,375 - 200,000 Total notes payable, related parties 2,093,981 1,146,500 Less: unamortized debt discounts 3,861 - Notes payable, related parties, net of discounts 2,090,120 1,146,500 Less: current maturities - 1,146,500 Notes payable, related parties, long-term portion $ 2,090,120 $ - The Company recorded interest expense pursuant to the stated interest rates on the notes payable, related parties, in the amount of $ 118,599 58,804 5,978 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2024
Notes Payable
Notes Payable	Note 12 – Notes Payable Schedule of Notes Payable September 30, December 31, 2024 2023 On April 19, 2024, the “Company completed the sale of a 12 1,300,000 1,196,000 The Note matures on January 19, 2025 12 Pursuant to the Purchase Agreement with SDT, SDT received a pre-funded warrant to purchase 8,666,667 520,000 351,638 A portion of the proceeds were used to repay the $ 360,000 257,446 207,000 50,446 $ 1,300,000 $ - On April 19, 2024, the “Company completed the sale of a 12 300,000 276,000 The Fourth AJB Note matures on January 19, 2025 12 Pursuant to the Purchase Agreement with AJB, the Company paid a $ 120,000 2,000,000 80,185 300,000 - On March 4, 2024, the Company completed the sale of a promissory note to the Sanguine Group, LLC (“Sanguine”) in the principal amount of $ 360,000 300,000 60,000 September 4, 2024 15 15,000 2,500,000 300,000 Pursuant to the Purchase Agreement, the Company paid a commitment fee to Sanguine in the form of 2,500,000 73,454 363,300 360,000 3,300 - - ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On August 18, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note of $ 35,000 10 15 35,000 35,000 On June 23, 2023, the Company completed the sale of a Promissory Note in the principal amount of $ 300,000 276,000 262,500 24,000 7,500 6,000 The Third AJB Note matured on March 23, 2024 12 10 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 100,000 1,666,667 42,175 In connection with the issuance of the Third AJB Note and Commitment Fee Shares, the Company entered into a Registration Rights Agreement with AJB Capital in which the Company agreed to file a registration statement with the SEC within 180 days of June 23, 2023, registering the shares of common stock issuable under the Third AJB Note and Purchase Agreement. The note was repaid on March 14, 2024 out of the proceeds received from the Sanguine Group Note. - 300,000 Total notes payable 1,635,000 335,000 Less: unamortized debt discounts 237,468 24,136 Notes payable, net of discounts 1,397,532 310,864 Less: current maturities 1,397,532 310,864 Notes payable, long-term portion $ - $ - ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) The Company recognized aggregate debt discounts on the notes payable to for the nine months ended September 30, 2024, as follows: Schedule of Notes Payable Debt Discounts September 30, December 31, 2024 2023 Fair value of commitment shares of common stock $ 163,477 $ 42,175 Fair value of pre-funded warrants 351,638 - Original issue discounts 188,000 24,000 Legal and brokerage fees 43,500 13,500 Total debt discounts 746,615 79,675 Amortization of debt discounts 505,286 26,233 Unamortized debt discounts $ 241,329 $ 53,442 The aggregate debt discounts of $ 736,776 79,675 523,444 26,233 The convertible note limits the maximum number of shares that can be owned by the note holder as a result of the conversions to common stock to 4.99 The Company recorded interest expense pursuant to the stated interest rates on the notes payable in the amount of $ 103,446 47,255 The Company recognized interest expense for the nine months ended September 30, 2024 and 2023, as follows: Schedule of Interest Expenses September 30, September 30, 2024 2023 Interest on convertible notes, related party $ 15,123 $ 44,877 Interest on notes payable, related parties 112,621 58,804 Interest on notes payable 103,446 47,255 Amended warrants 51,008 - Amortization of debt discounts, related parties 5,978 - Amortization of debt discounts, common stock 134,049 12,684 Amortization of debt discounts, warrants 209,703 - Amortization of debt discounts 179,692 13,549 Total interest expense $ 811,620 $ 177,169

Convertible Preferred Stock

Convertible Preferred Stock	9 Months Ended
	Sep. 30, 2024
Convertible Preferred Stock
Convertible Preferred Stock	Note 13 – Convertible Preferred Stock Preferred Stock The Company has 10,000,000 0.001 500,000 600,000 The shares of Series A Preferred Stock and Series B Preferred Stock are each currently convertible into one hundred (100) shares of the Company’s common stock. The Series A Preferred Stock accrues dividends at the rate of 6 114,733 238,501 10 15 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) The Series A and B Preferred Stock have been classified outside of permanent equity and liabilities. the Series A Preferred Stock embodies conditional obligations that the Company may settle by issuing a variable number of equity shares, and in both the Series A and B Preferred Stock, monetary value of the obligation is based on a fixed monetary amount known at inception. Series A Preferred Stock Sale to Director On July 25, 2024, the Company received proceeds of $ 150,000 15,000 15,000 five 1,500,000 0.25 152 0.0272 40,873 Cancellation of Series A Preferred Stock Subscriptions Payable On July 3, 2024, a consultant agreed to forfeit 4,500 45,000 Preferred Stock Dividends The Series A Preferred Stock accrues dividends at the rate of 6 44,915 43,808 241,649

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 14 – Commitments and Contingencies Debt Commitment Obligations The Company has entered into various forms of debt financing that require the Company to issue shares of common stock or pre-funded warrants that carry certain make-whole provisions whereby, if the debt holder is unable to sell the commitment fee shares for net proceeds equal to at least the commitment fee, the Company shall pay the shortfall in cash, or cause the issuance of additional shares of common stock, to the debt holder until the sale of which would ultimately generate total net funds equal to the commitment fee, as follows: Schedule of Debt Commitments and Contingencies Debt Holder Commitment Shares or Warrants Commitment Amounts SDT Equities Note 8,666,667 * $ 520,000 Fourth AJB Note 2,000,000 $ 120,000 Third AJB Note 1,666,667 $ 100,000 * If, as of the date of the delivery by Holder of the Sale Reconciliation Notice, the Holder has not realized net proceeds from the sale of such Warrant Shares equal to at least the $ 520,000 Equity Line of Credit On September 1, 2022, the Company entered into a Purchase Agreement (the “ELOC Purchase Agreement”) with Tysadco Partners, LLC (“Tysadco”). Pursuant to the ELOC Purchase Agreement, Tysadco has agreed to purchase from the Company, from time to time upon delivery by the Company to Tysadco of “Request Notices,” and subject to the other terms and conditions set forth in the ELOC Purchase Agreement, up to an aggregate of $ 10,000,000 The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) In connection with the ELOC Purchase Agreement, the Company entered into a Registration Rights Agreement with Tysadco under which the Company agreed to file a registration statement with the Securities and Exchange Commission covering the shares of common stock issuable under the ELOC Purchase Agreement and conversion of the Commitment Fee Shares (the “Registration Rights Agreement”). There have not been any advances on this arrangement to date.

Changes in Stockholders_ Equity

Changes in Stockholders’ Equity	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Changes in Stockholders’ Equity	Note 15 – Changes in Stockholders’ Equity Common Stock The Company is authorized to issue an aggregate of 1,000,000,000 0.001 105,890,570 Common Stock Issued in Escrow Pursuant to Default Provisions of Debt Financing On March 4, 2024, the Company issued 10,394,610 Common Stock Issued as a Promissory Note Commitment On April 19, 2024, the Company paid a commitment fee to AJB Capital in the form of 2,000,000 80,185 On March 19, 2024, the Company paid a commitment fee to Joerg Sommer, the Company’s President, in the form of 250,000 9,839 On March 4, 2024, the Company paid a commitment fee to The Sanguine Group, LLC in the form of 2,500,000 73,454 Common Stock Issued as Consideration for Related Party Debt Modifications On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., agreed to issue shares of common stock to officers and directors in consideration for extending the maturity dates and terms of previously received debt financing, as listed below. The aggregate fair value of the common stock was $ 724,086 March 1, 2027 10 7 Schedule of Consideration For Related Party Debt Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Common Stock Issued for Services, Related Parties On September 25, 2024, the Company issued 600,000 The fair value of the 15,000 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On July 1, 2024, the Company issued 250,000 The fair value of the 11,250 On March 15, 2024, the Company issued shares of common stock to officers and directors for services provided, as listed below. The aggregate fair value of the common stock was $ 429,000 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000 Common Stock Issued for Services On September 30, 2024, the Company issued 278,811 8,671 On July 1, 2024, the Company issued 200,000 The fair value of the 9,000 On June 30, 2024, the Company awarded 231,840 12,473 On May 10, 2024, the Company issued 1,250,000 The fair value of the 76,250 On March 31, 2024, the Company awarded 381,680 24,695 On March 15, 2024, the Company issued an aggregate 500,000 33,000 On February 9, 2024, the Company issued 149,621 5,386 Amortization of Stock-Based Compensation A total of $ 11,597 121,052 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Common Stock Options

Common Stock Options	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Common Stock Options	Note 16 – Common Stock Options Stock Incentive Plan On February 12, 2020, the Company’s stockholders approved our 2019 Stock Incentive Plan (the “2019 Plan”), which had been adopted by the Company’s Board of Directors (the “Board”) as of December 10, 2019. The 2019 Plan provides for the issuance of up to 10,000,000 Outstanding Options Options to purchase an aggregate total of 10,892,000 0.14 6.49 The Company recognized a total of $ 11,597 121,052 17,941

Warrants

Warrants	9 Months Ended
	Sep. 30, 2024
Warrants
Warrants	Note 17 – Warrants Outstanding Warrants Warrants to purchase an aggregate total of 24,178,317 0.18 5.1 Amendment of Warrants On September 17, 2024, the Board approved the extension of warrants previously awarded to AJB Capital Investments LLC as part of debt financing that originated on September 24, 2021, whereby the Company’s originally issued warrants consisting of, (i) a three 1,500,000 0.25 three 2,000,000 0.50 168 0.0147 51,008 Series A Preferred Stock Sale to Director On July 25, 2024, the Company received proceeds of $ 150,000 15,000 15,000 five 1,500,000 0.25 152 0.0272 40,873 Warrants Issued for Debt Financing On April 19, 2024, the Company completed the sale of a (i) Promissory Note in the principal amount of $ 1,300,000 8,666,667 0.00001 1,175,500 520,000 146 0.0640 554,862 351,638 209,704 141,935 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 18 – Income Taxes The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. For the nine months ended September 30, 2024, and the year ended December 31, 2023, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At September 30, 2024, the Company had approximately $ 11,388,000 The net operating loss carry forwards, if not utilized, will begin to expire in 2025. Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at September 30, 2024 and December 31, 2023, respectively. In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 19 – Subsequent Events The Company evaluates events that have occurred after the balance sheet date through the date these financial statements were issued , noting no reportable event, except as follows: Liquidation Proceeding Effective October 1, 2024, the Company’s Colombian subsidiary, One World Pharma S.A.S. (“OWP Colombia”), entered into a liquidation proceeding pursuant to Colombian Law 1116 of 2006, under which the creditors of a company can request “judicial liquidation” of such company. The proceeding is expected to last approximately one year. The proceeding was submitted to the Superintendent of Corporations of Colombia as a substitute to the reorganization proceedings previously filed on December 22, 2023. The operations of OWP Colombia have previously been deconsolidated. As such, we do not expect the judicial liquidation to have a significant impact to the Company’s financial statements. Increase in Authorized Common Stock On October 15, 2024, the holders of a majority of the voting power of the Company approved an increase in the number of authorized shares of common stock to 1 Designation of Series C Special Preferred Stock On October 10, 2024, the Company filed with the State of Nevada a Certificate of Designation (the “ Section 1. Designation, Amount and Par Value 0.001 Section 2. Fractional Shares Section 3. Voting Rights ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) (a) The total number of shares of common stock which are issued and outstanding at the time of any election or vote by the shareholders; plus (b) The number of votes allocated to shares of Preferred Stock issued and outstanding of any other class that shall have voting rights. Section 4. Dividends Section 5. Liquidation Section 6. Conversion Section 7. Protection Provisions Section 8. Waiver Section 9. No Other Rights or Privileges Issuance of Series C Special Preferred Stock Effective November 8, 2024, the Company entered into an Exchange Agreement (the “Thomas Agreement”) with Isiah L. Thomas, III, the Company’s Chairman and Chief Executive Officer, pursuant to which the Company issued 100 486,512

Nature of Business and Signif_2

Nature of Business and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Nature of Business	Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, the Company entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., a wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian Simplified Shares Company (“OWP SAS”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP SAS) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP SAS. OWP SAS is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). The Company had intended to be a producer of and/or source raw and processed cannabis and hemp plant ingredients for both medical and industrial uses across the globe. The Company received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, the Company was one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, the Company owns approximately 30 acres and has a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. During the first quarter of 2022, the Company made payments of approximately $ 1,400,000 On December 22, 2023, OWP SAS, f iled for protection under Colombian Law 1116 of 2006, which is the primary legislation governing business insolvency proceedings (restructuring and liquidation) (“Reorganization Proceedings”) in Colombia. In connection with the Reorganization Proceedings, OWP SAS paused production and sales of our cannabis operations in Colombia until the Court provided the Company with a plan of reorganization, at which time the Company intended to resume operations and satisfy its obligations in Colombia in accordance with the court’s plan, however, the Company now intends to have the Court liquidate its assets and pay its creditors out of the proceeds of the liquidation. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) In accordance with ASC 810-10-15, the Company has deconsolidated its foreign subsidiaries to include the petitioning entity, OWP SAS, as well as the Company’s non-operating shell entities, Agrobase, S.A.S. and Hope Colombia, S.A.S., given the lack of independently identifiable operations. The deconsolidation resulted in a loss on deconsolidation of foreign subsidiaries in the amount of $ 242,631 1,564,823 During March of 2024, the Company, through OWP Ventures, began to sell a CBD based product in the United States, called Pro-11. During the fourth quarter of 2024, the Company began to redesign the packaging and engaged a sales representative to focus greater resources on bringing this product to market. On May 15, 2024, OWP Ventures, Inc., acquired Pétalo Pharmaceutical, S.A.S. (“Pétalo”), a Company located in Colombia and legally constituted as a simplified stock company that owns licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes from the free trade zone in Colombia. Pétalo had no operations, other than obtaining four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export from the free trade zone. The acquisition was accounted for as an asset purchase, and the $ 75,000 During 2024, the Company has also been developing industrial hemp solutions for the automotive market. The Company intends to focus increased efforts on research and development in this area to help the automotive industry meet its goals of achieving carbon neutral manufacturing using renewable material solutions. In October of 2024, the Company, in collaboration with partners in the automotive industry, developed hemp-based molded containers for automotive part packaging applications and received an initial order for 1,400 units of these reusable totes, designed to move and protect automotive parts through the supply chain.
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. The unaudited condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Such adjustments are of a normal, recurring nature. The Condensed Consolidated Financial Statements, and the accompanying notes, are prepared in accordance with GAAP and do not contain certain information included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The interim Condensed Consolidated Financial Statements should be read in conjunction with that Annual Report on Form 10-K. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2024: Schedule of Common Control and Ownership Interest Jurisdiction of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary Pétalo Pharmaceutical, S.A.S. (3) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on May 15, 2024, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Reclassifications	Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings.
Foreign Currency Translation	Foreign Currency Translation The functional currency of the Company is Colombian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar (USD) throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods.
Comprehensive Income	Comprehensive Income The Company has adopted the Financial Accounting Standards Boards (“FASB”) Accounting Standards Codification (“ASC”) 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Segment Reporting	Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820 – Fair Value Measurement and Disclosures (ASC 820). Under ASC 820-10-05, the FASB establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses reported on the balance sheets are estimated by management to approximate fair value primarily due to the short-term nature of the instruments.
Cash in Excess of FDIC Insured Limits	Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 no
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s revenues in the current period consisted of the sale of our CBD rub, and in the prior period revenues consisted entirely of the sale of seeds. The sale of seeds included multi-element arrangements whereby the Company collected 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company had a right of first refusal to purchase products resulting from the harvest. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In December 2023 , FASB issued “Income Taxes (Topic ): Improvements to Income Tax Disclosures,” , There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

Nature of Business and Signif_3

Nature of Business and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Schedule of Common Control and Ownership Interest	The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at September 30, 2024: Schedule of Common Control and Ownership Interest Jurisdiction of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary Pétalo Pharmaceutical, S.A.S. (3) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on May 15, 2024, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.

Deconsolidation of Foreign Su_2

Deconsolidation of Foreign Subsidiaries (Tables)	9 Months Ended
	Sep. 30, 2024
Deconsolidation Of Foreign Subsidiaries
Schedule of Deconsolidated Balance Sheets and Statement of Operations and Comprehensive Loss of Foreign Subsidiaries	Schedule of Deconsolidated Balance Sheets and Statement of Operations and Comprehensive Loss of Foreign Subsidiaries FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, December 31, 2024 2023 Assets Current assets: Cash $ 8,472 $ 1,660 Inventory 37,393 45,791 Other current assets 15,971 2,687 Total current assets 61,836 50,138 Other assets 207,928 226,542 Fixed assets, net 2,306,501 2,346,281 Total Assets $ 2,576,265 $ 2,622,961 Liabilities and Stockholders’ Equity (Deficit) Current liabilities: Accounts payable $ 331,121 $ 392,403 Accrued expenses 481,277 482,587 Notes payable 168,099 183,148 Intercompany liabilities owed to OWP Ventures, Inc. 7,737,202 7,348,034 Total current liabilities 8,717,699 8,406,172 Stockholders’ Equity (Deficit): Accumulated other comprehensive income 62,311 - Accumulated (deficit) (6,203,745 ) (5,783,211 ) Total Stockholders’ Equity (Deficit) (6,141,434 ) (5,783,211 ) Total Liabilities and Stockholders’ Equity (Deficit) $ 2,576,265 $ 2,622,961 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS For the Three For the Nine Months Ended Months Ended September 30, September 30, 2024 2024 Revenues $ - $ - Cost of goods sold - - Gross profit - - Operating expenses: General and administrative 67,115 208,062 Professional fees 12,121 44,250 Depreciation expense 13,260 39,780 Total operating expenses 92,496 292,092 Operating loss (92,496 ) (292,092 ) Other income (expense): Interest expense (48,329 ) (128,442 ) Total other expense (48,329 ) (128,442 ) Net loss $ (140,825 ) $ (420,534 ) Other comprehensive loss: Gain on foreign currency translation $ 3,625 $ 62,311 Net loss $ (137,200 ) $ (358,223 ) FOREIGN SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS For the Nine Months Ended September 30, 2024 Cash flows from operating activities Net loss $ (420,534 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization expense 39,780 Decrease (increase) in assets: Inventory 8,398 Other current assets (13,284 ) Other assets 18,614 Increase (decrease) in liabilities: Accounts payable (61,282 ) Accrued expenses (16,359 ) Accrued interest on intercompany loans 104,210 Net cash used in operating activities (340,457 ) Cash flows from financing activities Proceeds received from intercompany loan 284,958 Net cash provided by financing activities 284,958 Effect of exchange rate changes on cash 62,311 Net increase (decrease) in cash 6,812 Cash - beginning 1,660 Cash - ending $ 8,472 Supplemental disclosures: Interest paid $ - Income taxes paid $ -

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Schedule of Related Party Debt Modification	Schedule of Related Party Debt Modification Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Investments, All Other Investments [Abstract]
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis	The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheet as of September 30, 2024 and December 31, 2023, respectively: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at September 30, 2024 Level 1 Level 2 Level 3 Assets Cash $ 81,630 $ - $ - Total assets 81,630 - - Liabilities Convertible notes payable, related party - - - Notes payable, related parties, net of $ 7,153 - 2,090,120 - Notes payable, net of $ 434,289 - 1,397,532 - Total liabilities - (3,487,652 ) - Fair Value, Net Asset (Liability) $ 81,630 $ (3,487,652 ) $ - Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2023 Level 1 Level 2 Level 3 Assets Cash $ 726 $ - $ - Total assets 726 - - Liabilities Convertible notes payable, related party - 750,000 - Notes payable, related parties - 1,146,500 - Notes payable, net of $ 24,136 - 310,864 - Total liabilities - (2,207,364 ) - Fair Value, Net Asset (Liability) $ 726 $ (2,207,364 ) $ -

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following at September 30, 2024 and December 31, 2023, respectively: Schedule of Accrued Expenses September 30, December 31, 2024 2023 Accrued compensation $ 905,872 $ 665,417 Accrued interest 149,663 273,951 Accrued expenses $ 1,055,535 $ 939,368

Convertible Note Payable, Rel_2

Convertible Note Payable, Related Party (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Note Payable Related Party	Convertible note payable, related party consists of the following at September 30, 2024 and December 31, 2023, respectively: Schedule of Convertible Note Payable Related Party September 30, December 31, 2024 2023 On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 September 16, 2024 8 15 750,000 90,740 March 1, 2027 7 9,017,000 595,122 $ - $ 750,000 Total convertible note payable, related party - 750,000 Less: current maturities - - Convertible note payable, related party, long-term portion $ - $ 750,000

Notes Payable, Related Parties

Notes Payable, Related Parties (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Payable Related Parties
Schedule of Notes Payable Related Party	Notes payable, related parties, consists of the following at September 30, 2024 and December 31, 2023, respectively: Schedule of Notes Payable Related Party September 30, December 31, 2024 2023 On March 19, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 March 1, 2027 10 $ 50,000 $ - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 26,116 March 1, 2027 10 25,000 1,116 26,116 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 1,803,398 March 1, 2027 7 840,740 750,000 90,740 962,658 850,000 112,658 1,803,398 - On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 337,000 March 1, 2027 10 337,000 150,000 187,000 - ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On March 15, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $ 27,467 March 1, 2027 10 24,500 2,967 27,467 - On March 12, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 10 101,123 100,000 1,123 - - On March 1, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 March 1, 2025 8 March 1, 2027 - - On February 26, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 27,000 10 27,414 27,000 414 - - On January 29, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 January 29, 2025 8 March 1, 2027 - - On January 11, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,279 10,000 279 - - On January 8, 2024, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 10 10,288 10,000 288 - - On November 28, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 60,000 10 62,400 60,000 2,400 - 60,000 On October 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 25,000 10 March 1, 2027 - 25,000 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On September 11, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 52,000 10 March 1, 2027 2,650 - 52,000 On August 31, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,000 6 March 1, 2027 130 - 4,000 On August 14, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 6,000 6 March 1, 2027 211 - 6,000 On August 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 50,000 6 March 1, 2027 4,833 - 50,000 On August 2, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 4,500 6 March 1, 2027 - 4,500 On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 8 March 1, 2027 - 100,000 On July 7, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 5,000 6 March 1, 2027 507 - 5,000 On June 3, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 10,000 6 March 1, 2027 - 10,000 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On May 5, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 20,000 6 2,236 - 20,000 On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 8 March 1, 2027 - 400,000 On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 - 200,000 On December 29, 2021, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 8 March 1, 2027 35,375 - 200,000 Total notes payable, related parties 2,093,981 1,146,500 Less: unamortized debt discounts 3,861 - Notes payable, related parties, net of discounts 2,090,120 1,146,500 Less: current maturities - 1,146,500 Notes payable, related parties, long-term portion $ 2,090,120 $ -

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Payable
Schedule of Notes Payable	Schedule of Notes Payable September 30, December 31, 2024 2023 On April 19, 2024, the “Company completed the sale of a 12 1,300,000 1,196,000 The Note matures on January 19, 2025 12 Pursuant to the Purchase Agreement with SDT, SDT received a pre-funded warrant to purchase 8,666,667 520,000 351,638 A portion of the proceeds were used to repay the $ 360,000 257,446 207,000 50,446 $ 1,300,000 $ - On April 19, 2024, the “Company completed the sale of a 12 300,000 276,000 The Fourth AJB Note matures on January 19, 2025 12 Pursuant to the Purchase Agreement with AJB, the Company paid a $ 120,000 2,000,000 80,185 300,000 - On March 4, 2024, the Company completed the sale of a promissory note to the Sanguine Group, LLC (“Sanguine”) in the principal amount of $ 360,000 300,000 60,000 September 4, 2024 15 15,000 2,500,000 300,000 Pursuant to the Purchase Agreement, the Company paid a commitment fee to Sanguine in the form of 2,500,000 73,454 363,300 360,000 3,300 - - ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) On August 18, 2023, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note of $ 35,000 10 15 35,000 35,000 On June 23, 2023, the Company completed the sale of a Promissory Note in the principal amount of $ 300,000 276,000 262,500 24,000 7,500 6,000 The Third AJB Note matured on March 23, 2024 12 10 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 100,000 1,666,667 42,175 In connection with the issuance of the Third AJB Note and Commitment Fee Shares, the Company entered into a Registration Rights Agreement with AJB Capital in which the Company agreed to file a registration statement with the SEC within 180 days of June 23, 2023, registering the shares of common stock issuable under the Third AJB Note and Purchase Agreement. The note was repaid on March 14, 2024 out of the proceeds received from the Sanguine Group Note. - 300,000 Total notes payable 1,635,000 335,000 Less: unamortized debt discounts 237,468 24,136 Notes payable, net of discounts 1,397,532 310,864 Less: current maturities 1,397,532 310,864 Notes payable, long-term portion $ - $ -
Schedule of Notes Payable Debt Discounts	The Company recognized aggregate debt discounts on the notes payable to for the nine months ended September 30, 2024, as follows: Schedule of Notes Payable Debt Discounts September 30, December 31, 2024 2023 Fair value of commitment shares of common stock $ 163,477 $ 42,175 Fair value of pre-funded warrants 351,638 - Original issue discounts 188,000 24,000 Legal and brokerage fees 43,500 13,500 Total debt discounts 746,615 79,675 Amortization of debt discounts 505,286 26,233 Unamortized debt discounts $ 241,329 $ 53,442
Schedule of Interest Expenses	The Company recognized interest expense for the nine months ended September 30, 2024 and 2023, as follows: Schedule of Interest Expenses September 30, September 30, 2024 2023 Interest on convertible notes, related party $ 15,123 $ 44,877 Interest on notes payable, related parties 112,621 58,804 Interest on notes payable 103,446 47,255 Amended warrants 51,008 - Amortization of debt discounts, related parties 5,978 - Amortization of debt discounts, common stock 134,049 12,684 Amortization of debt discounts, warrants 209,703 - Amortization of debt discounts 179,692 13,549 Total interest expense $ 811,620 $ 177,169

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Debt Commitments and Contingencies	Schedule of Debt Commitments and Contingencies Debt Holder Commitment Shares or Warrants Commitment Amounts SDT Equities Note 8,666,667 * $ 520,000 Fourth AJB Note 2,000,000 $ 120,000 Third AJB Note 1,666,667 $ 100,000 * If, as of the date of the delivery by Holder of the Sale Reconciliation Notice, the Holder has not realized net proceeds from the sale of such Warrant Shares equal to at least the $ 520,000

Changes in Stockholders_ Equi_2

Changes in Stockholders’ Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Consideration For Related Party Debt	Schedule of Consideration For Related Party Debt Aggregate Name Position Debts Extended Shares Fair Value Isiah L. Thomas, III Chairman and CEO $ 27,467 138,000 $ 9,108 Dr. Kenneth Perego, II Vice Chairman 337,000 1,685,000 111,210 Joerg Sommer President 26,116 131,000 8,646 Dr. John McCabe >5% Shareholder 1,803,398 9,017,000 595,122 $ 2,193,981 10,971,000 $ 724,086 Name Position Shares Fair Value Isiah L. Thomas, III Chairman and CEO 2,000,000 $ 132,000 Dr. Kenneth Perego, II Vice Chairman 2,000,000 132,000 Terry Buffalo Director 2,000,000 132,000 Joerg Sommer President 500,000 33,000 6,500,000 $ 429,000

Schedule of Common Control and

Schedule of Common Control and Ownership Interest (Details)	9 Months Ended
	Sep. 30, 2024
Name of Entity	ONE WORLD PRODUCTS, INC.
State of incorporation	NV
One World Products, Inc. [Member]
Name of Entity	One World Products, Inc.	[1]
State of incorporation	NV	[1]
Relationship	Parent	[1]
OWP Ventures, Inc. [Member]
Name of Entity	OWP Ventures, Inc.	[2]
State of incorporation	DE	[2]
Relationship	Subsidiary	[2]
Petalo Pharmaceutical, S.A.S [Member]
Name of Entity	Pétalo Pharmaceutical, S.A.S.	[3]
State of incorporation	F8	[3]
Relationship	Subsidiary	[3]
[1]Holding company in the form of a corporation.[2]Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc.[3]Wholly-owned subsidiary of OWP Ventures, Inc., acquired on May 15, 2024, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.

Nature of Business and Signif_4

Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)			3 Months Ended			9 Months Ended		12 Months Ended
	May 15, 2024	Feb. 21, 2019	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Loss on deconsolidation of foreign subsidiaries			$ 22,359			$ 242,631		$ 1,564,823
Purchase price of license fair value						75,000
FDIC insured amount			250,000			250,000
Cash uninsured amount			$ 0			$ 0
Petalo Pharmaceutical, S.A.S [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchase price of license fair value	$ 75,000
Merger Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share based payment award shares purchased		825,000
Share price		$ 0.50
Merger Agreement [Member] | OWP Ventures, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Business acquisition, equity interest issued or issuable, number of shares		39,475,398
Share based payment award shares purchased		825,000
Share price		$ 0.50
Proceeds from convertible debt		$ 300,000
Conversion price		$ 0.424
Common stock shares cancelled		875,000
Payments for custom clearance					$ 1,400,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash on hand	$ 81,630	$ 726
Working capital	3,154,500
Accumulated deficit	$ 30,230,366	$ 26,929,686

Schedule of Deconsolidated Bala

Schedule of Deconsolidated Balance Sheet of Foreign Subsidiaries (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 81,630		$ 726
Inventory	16,633
Total current assets	115,183		13,882
Total Assets	275,183		98,882
Current liabilities:
Accounts payable	574,967		528,645
Accrued expenses	1,055,535		939,368
Total current liabilities	3,269,683		3,872,111
Stockholders’ Equity (Deficit):
Accumulated other comprehensive income			42,328
Accumulated (deficit)	(30,230,366)		(26,929,686)
Total Stockholders’ Equity (Deficit)	(9,809,465)	$ (9,158,605)	(8,348,074)	$ (6,210,988)	$ (6,244,487)	$ (5,836,258)
Total Liabilities and Stockholders’ Equity (Deficit)	275,183		98,882
Subsidiaries [Member]
Current assets:
Cash	8,472		1,660
Inventory	37,393		45,791
Other current assets	15,971		2,687
Total current assets	61,836		50,138
Other assets	207,928		226,542
Fixed assets, net	2,306,501		2,346,281
Total Assets	2,576,265		2,622,961
Current liabilities:
Accounts payable	331,121		392,403
Accrued expenses	481,277		482,587
Notes payable	168,099		183,148
Intercompany liabilities owed to OWP Ventures, Inc.	7,737,202		7,348,034
Total current liabilities	8,717,699		8,406,172
Stockholders’ Equity (Deficit):
Accumulated other comprehensive income	62,311
Accumulated (deficit)	(6,203,745)		(5,783,211)
Total Stockholders’ Equity (Deficit)	(6,141,434)		(5,783,211)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 2,576,265		$ 2,622,961

Schedule of Deconsolidated Stat

Schedule of Deconsolidated Statement of Operations and Comprehensive Loss of Foreign Subsidiaries (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues	$ 1,517	$ 5,906	$ 3,053	$ 8,082
Cost of goods sold	310	767	588	1,866
Gross loss	1,207	5,139	2,465	6,216
Operating expenses:
General and administrative	203,242	142,464	552,874	907,595
Professional fees	169,596	236,139	971,934	413,651
Depreciation expense		9,274		25,578
Total operating expenses	372,838	387,877	1,524,808	1,346,824
Operating loss	(371,631)	(382,738)	(1,522,343)	(1,340,608)
Other income (expense):
Interest expense			(811,620)	(177,169)
Total other expense	(362,968)	(67,568)	(1,778,337)	(172,766)
Net loss	(734,599)	(450,306)	(3,300,680)	(1,513,374)
Other comprehensive loss:
Gain on foreign currency translation		(32,831)	(42,328)	145,370
Net other comprehensive loss	(734,599)	$ (483,137)	(3,343,008)	$ (1,368,004)
Subsidiaries [Member]
Revenues
Cost of goods sold
Gross loss
Operating expenses:
General and administrative	67,115		208,062
Professional fees	12,121		44,250
Depreciation expense	13,260		39,780
Total operating expenses	92,496		292,092
Operating loss	(92,496)		(292,092)
Other income (expense):
Interest expense	(48,329)		(128,442)
Total other expense	(48,329)		(128,442)
Net loss	(140,825)		(420,534)
Other comprehensive loss:
Gain on foreign currency translation	3,625		62,311
Net other comprehensive loss	$ (137,200)		$ (358,223)

Schedule of Deconsolidated St_2

Schedule of Deconsolidated Statement of Cash Flows of Foreign Subsidiaries (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (734,599)	$ (450,306)	$ (3,300,680)	$ (1,513,374)
Decrease (increase) in assets:
Inventory			(16,633)	(258,583)
Other current assets			(3,585)	20,219
Other assets				(33,666)
Increase (decrease) in liabilities:
Accounts payable			46,322	17,774
Accrued expenses			323,648	290,021
Net cash used in operating activities			(1,010,268)	(1,043,238)
Cash flows from financing activities
Net cash provided by financing activities			1,208,500	874,500
Effect of exchange rate changes on cash			(42,328)	172,920
Net increase in cash			80,904	(864)
Cash - beginning			726	11,016
Cash - ending	81,630	$ 10,152	81,630	10,152
Supplemental disclosures:
Interest paid			147,996	40,693
Income taxes paid
Subsidiaries [Member]
Cash flows from operating activities
Net loss	(140,825)		(420,534)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense			39,780
Decrease (increase) in assets:
Inventory			8,398
Other current assets			(13,284)
Other assets			18,614
Increase (decrease) in liabilities:
Accounts payable			(61,282)
Accrued expenses			(16,359)
Accrued interest on intercompany loans			104,210
Net cash used in operating activities			(340,457)
Cash flows from financing activities
Proceeds received from intercompany loan			284,958
Net cash provided by financing activities			284,958
Effect of exchange rate changes on cash			62,311
Net increase in cash			6,812
Cash - beginning			1,660
Cash - ending	$ 8,472		8,472
Supplemental disclosures:
Interest paid
Income taxes paid

Deconsolidation of Foreign Su_3

Deconsolidation of Foreign Subsidiaries (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 22, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Deconsolidation Of Foreign Subsidiaries
Financial obligations	$ 1,200,000
Loss on deconsolidation of foreign subsidiaries		$ 22,359		$ 242,631		$ 1,564,823

Schedule of Related Party Debt

Schedule of Related Party Debt Modification (Details)	Mar. 15, 2024 USD ($) shares
Related Party Transaction [Line Items]
Aggregate debts extended	$ 2,193,981
Shares | shares	10,971,000
Fair value	$ 724,086
Common Stock [Member]
Related Party Transaction [Line Items]
Shares | shares	6,500,000
Fair value	$ 429,000
Isiah Thomas III [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 27,467
Shares | shares	138,000
Fair value	$ 9,108
Isiah Thomas III [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares | shares	2,000,000
Fair value	$ 132,000
Dr.Kenneth Perego II [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 337,000
Shares | shares	1,685,000
Fair value	$ 111,210
Dr.Kenneth Perego II [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares | shares	2,000,000
Fair value	$ 132,000
Mr Joerg Sommer [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 26,116
Shares | shares	131,000
Fair value	$ 8,646
Mr Joerg Sommer [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares | shares	500,000
Fair value	$ 33,000
Dr John McCabe [Member]
Related Party Transaction [Line Items]
Aggregate debts extended	$ 1,803,398
Shares | shares	9,017,000
Fair value	$ 595,122
Terry Buffalo [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares | shares	2,000,000
Fair value	$ 132,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative)								9 Months Ended
	Sep. 25, 2024 USD ($) shares	Jul. 26, 2024 USD ($)	Jul. 25, 2024 USD ($) $ / shares shares	Jul. 01, 2024 USD ($) shares	Apr. 22, 2024 USD ($)	Mar. 15, 2024 USD ($)	Mar. 04, 2024 shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) shares	Sep. 17, 2024 $ / shares shares	Apr. 19, 2024 USD ($) $ / shares
Related Party Transaction [Line Items]
Warrants shares | shares								24,178,317
Warrants exercise price per share | $ / shares								$ 0.18
Repaid promissory notes								$ 660,000
Aggregate fair value of the common stock						$ 724,086
Maturity date						Mar. 01, 2027
Interest rate						10%
Interest rate percentage						7%
Aggregate fair value of the common stock									$ 300,000
Kenneth Perego II, M.D [Member]
Related Party Transaction [Line Items]
Aggregate debt amount					$ 257,446
Principal amount					207,000
Interest amount					$ 50,446
Dr Kenneth Perego [Member]
Related Party Transaction [Line Items]
Repaid debt		$ 150,000
Repaid promissory notes		$ 337,000
Warrant [Member]
Related Party Transaction [Line Items]
Warrants shares | shares										1,500,000
Warrants exercise price per share | $ / shares										$ 0.25
Warrants and Rights Outstanding			$ 40,873								$ 554,862
Warrant [Member] | Measurement Input, Price Volatility [Member]
Related Party Transaction [Line Items]
Warrants and Rights Outstanding, Measurement Input			1.52							168	146
Warrant [Member] | Measurement Input, Share Price [Member]
Related Party Transaction [Line Items]
Warrants and Rights Outstanding, Measurement Input | $ / shares			0.0272							0.0147	0.0640
Common Stock [Member]
Related Party Transaction [Line Items]
New issuance of common stock | shares							10,394,610		3,000,000
Aggregate fair value of the common stock									$ 3,000
Common Stock [Member] | Chief Financial Officer [Member]
Related Party Transaction [Line Items]
New issuance of common stock | shares	600,000
Aggregate fair value of the common stock	$ 15,000
Common Stock [Member] | Todd Peterson [Member]
Related Party Transaction [Line Items]
New issuance of common stock | shares				250,000
Aggregate fair value of the common stock				$ 11,250
Common Stock [Member] | Officers and Directors [Member]
Related Party Transaction [Line Items]
Aggregate fair value of the common stock						$ 429,000
Series A Preferred Stock [Member]
Related Party Transaction [Line Items]
Proceeds from sale of units			$ 150,000
Sale of units | shares			15,000
New issuance of common stock | shares			15,000
Warrants shares | shares			1,500,000
Warrants exercise price per share | $ / shares			$ 0.25
Series A Preferred Stock [Member] | Warrant [Member]
Related Party Transaction [Line Items]
Warrants and Rights Outstanding			$ 40,873
Series A Preferred Stock [Member] | Warrant [Member] | Measurement Input, Price Volatility [Member]
Related Party Transaction [Line Items]
Warrants and Rights Outstanding, Measurement Input			152
Series A Preferred Stock [Member] | Warrant [Member] | Measurement Input, Share Price [Member]
Related Party Transaction [Line Items]
Warrants and Rights Outstanding, Measurement Input | $ / shares			0.0272

Schedule of Valuation of Financ

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Inputs, Level 1 [Member]
Assets
Cash	$ 81,630	$ 726
Total assets	81,630	726
Convertible notes payable, related party
Notes payable, related parties
Notes payable, net of $24,136 of debt discounts
Total liabilities
Fair Value, Net Asset (Liability)	81,630	726
Liabilities
Total liabilities
Fair Value, Inputs, Level 2 [Member]
Assets
Cash
Total assets
Convertible notes payable, related party		750,000
Notes payable, related parties	2,090,120	1,146,500
Notes payable, net of $24,136 of debt discounts	1,397,532	310,864
Total liabilities	(3,487,652)	(2,207,364)
Fair Value, Net Asset (Liability)	(3,487,652)	(2,207,364)
Liabilities
Total liabilities	(3,487,652)	(2,207,364)
Fair Value, Inputs, Level 3 [Member]
Assets
Cash
Total assets
Convertible notes payable, related party
Notes payable, related parties
Notes payable, net of $24,136 of debt discounts
Total liabilities
Fair Value, Net Asset (Liability)
Liabilities
Total liabilities

Schedule of Valuation of Fina_2

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) (Parenthetical) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Net of debt discount	$ 237,468	$ 24,136
Net of debt discount	434,289
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Net of debt discount	$ 7,153

Inventory (Details Narrative)

Inventory (Details Narrative) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Inventory, net	$ 16,633

Security Deposits (Details Narr

Security Deposits (Details Narrative) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Security deposits	$ 85,000	$ 85,000

Licenses (Details Narrative)

Licenses (Details Narrative) - USD ($)		9 Months Ended
	May 15, 2024	Sep. 30, 2024	Sep. 30, 2023
Purchase price of license fair value		$ 75,000
Petalo Pharmaceutical, S.A.S [Member]
Purchase price of license fair value	$ 75,000

Schedule of Accrued Expenses (D

Schedule of Accrued Expenses (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued compensation	$ 905,872	$ 665,417
Accrued interest	149,663	273,951
Accrued expenses	$ 1,055,535	$ 939,368

Schedule of Convertible Note Pa

Schedule of Convertible Note Payable Related Party (Details) - Related Party [Member] - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Total convertible note payable, related party		$ 750,000
Less: current maturities
Convertible note payable, related party, long-term portion		750,000
Promissory Note [Member]
Short-Term Debt [Line Items]
Total convertible note payable, related party		$ 750,000

Schedule of Convertible Note _2

Schedule of Convertible Note Payable Related Party (Details) (Parenthetical) - USD ($)	Mar. 15, 2024	Sep. 27, 2022
Short-Term Debt [Line Items]
Interest rate	7%
Promissory Note [Member] | John McCabe Investments LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 750,000	$ 750,000
Maturity date	Mar. 01, 2027	Sep. 16, 2024
Interest rate	7%	8%
Accrued interest	$ 90,740
Issuance of common stock	9,017,000
Aggregate fair value of the common stock	$ 595,122
Promissory Note [Member] | John McCabe Investments LLC [Member] | Series B Common Stock [Member]
Short-Term Debt [Line Items]
Conversion price		$ 15

Convertible Note Payable, Rel_3

Convertible Note Payable, Related Party (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Short-Term Debt [Line Items]
Interest expenses of convertible note	$ 15,123	$ 44,877
Convertible Debt [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Interest expenses of convertible note	$ 15,124	$ 44,877

Schedule of Notes Payable Relat

Schedule of Notes Payable Related Party (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Less: unamortized debt discounts	$ 3,861
Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts	2,090,120	$ 1,146,500
Less: unamortized debt discounts	3,861
Less: current maturities		1,146,500
Notes payable, related parties, long-term portion	2,090,120
Unsecured Promissory Note One [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts	50,000
Unsecured Promissory Note Two [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts	26,116
Unsecured Promissory Note Three [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts	1,803,398
Unsecured Promissory Note Four [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts	187,000
Unsecured Promissory Note Five [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts	27,467
Unsecured Promissory Note Six [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts
Unsecured Promissory Note Seven [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts
Unsecured Promissory Note Eight [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts
Unsecured Promissory Note Nine [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts
Unsecured Promissory Note Ten [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts
Unsecured Promissory Note Eleven [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts
Unsecured Promissory Note Twelve [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		60,000
Unsecured Promissory Note Thirteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		25,000
Unsecured Promissory Note Fourteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		52,000
Unsecured Promissory Note Fifeteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		4,000
Unsecured Promissory Note Sixteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		6,000
Unsecured Promissory Note Seventeen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		50,000
Unsecured Promissory Note Eighteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		4,500
Unsecured Promissory Note Nineteen [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		100,000
Unsecured Promissory Note Twenty [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		5,000
Unsecured Promissory Note Twenty One [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		10,000
Unsecured Promissory Note Twenty Two [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		10,000
Unsecured Promissory Note Twenty Three [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		20,000
Unsecured Promissory Note Twenty Four [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		400,000
Unsecured Promissory Note Twenty Five [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		200,000
Unsecured Promissory Note Twenty Six [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts		200,000
Unsecured Promissory Notes [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Notes payable, related parties, net of discounts	$ 2,093,981	$ 1,146,500

Schedule of Notes Payable Rel_2

Schedule of Notes Payable Related Party (Details) (Parenthetical) - USD ($)

9 Months Ended

Jul. 26, 2024

Apr. 22, 2024

Mar. 19, 2024

Mar. 15, 2024

Mar. 01, 2024

Jan. 29, 2024

Oct. 11, 2023

Sep. 11, 2023

Aug. 31, 2023

Aug. 14, 2023

Aug. 05, 2022

Aug. 02, 2022

Jul. 07, 2022

Jun. 13, 2022

Jun. 03, 2022

May 05, 2022

Mar. 01, 2022

Feb. 15, 2022

Dec. 29, 2021

Sep. 30, 2024

Sep. 30, 2023

Mar. 12, 2024

Feb. 26, 2024

Jan. 11, 2024

Jan. 08, 2024

Nov. 28, 2023

Short-Term Debt [Line Items]

Interest rate

7%

Debt instrument, face value

$ 15,123

$ 44,877

Unsecured Promissory Note One [Member] | Joerg Sommer [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 50,000

Maturity date

Mar. 01, 2027

Interest rate

10%

Unsecured Promissory Note Two [Member] | Joerg Sommer [Member]

Short-Term Debt [Line Items]

Maturity date

Mar. 01, 2027

Interest rate

10%

Debt instrument, face value

$ 26,116

Debt instrument, face value

25,000

Accrued interest

1,116

Unsecured Promissory Note Three [Member] | John McCabe Investments LLC [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 750,000

Maturity date

Mar. 01, 2027

Interest rate

7%

Debt instrument, face value

$ 1,803,398

Debt instrument, face value

840,740

Accrued interest

90,740

Other promissory note

962,658

Principal amount

850,000

Accrued interest

112,658

Unsecured Promissory Note Four [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 337,000

Maturity date

Mar. 01, 2027

Interest rate

10%

Debt instrument, face value

$ 337,000

Debt instrument, face value

$ 150,000

Unsecured Promissory Note Five [Member] | Isiah Thomas III [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 24,500

Maturity date

Mar. 01, 2027

Interest rate

10%

Debt instrument, face value

$ 27,467

Accrued interest

$ 2,967

Unsecured Promissory Note Six [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 100,000

$ 100,000

Interest rate

10%

Debt instrument, face value

101,123

Accrued interest

1,123

Unsecured Promissory Note Seven [Member] | John McCabe Investments LLC [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 100,000

Maturity date

Mar. 01, 2025

Interest rate

8%

Maturity date

Mar. 01, 2027

Unsecured Promissory Note Eight [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

27,000

$ 27,000

Interest rate

10%

Debt instrument, face value

27,414

Accrued interest

414

Unsecured Promissory Note Nine [Member] | John McCabe Investments LLC [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 50,000

Maturity date

Mar. 01, 2027

Jan. 29, 2025

Interest rate

8%

Unsecured Promissory Note Ten [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

10,000

$ 10,000

Interest rate

10%

Debt instrument, face value

10,279

Accrued interest

279

Unsecured Promissory Note Eleven [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

10,000

$ 10,000

Interest rate

10%

Debt instrument, face value

10,288

Accrued interest

288

Unsecured Promissory Note Twelve [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

60,000

$ 60,000

Interest rate

10%

Debt instrument, face value

62,400

Accrued interest

2,400

Unsecured Promissory Note Thirteen [Member] | Joerg Sommer [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 25,000

Maturity date

Mar. 01, 2027

Interest rate

10%

Unsecured Promissory Note Fourteen [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 52,000

Maturity date

Mar. 01, 2027

Interest rate

10%

Debt instrument, face value

2,650

Unsecured Promissory Note Fifeteen [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 4,000

Maturity date

Mar. 01, 2027

Interest rate

6%

Debt instrument, face value

130

Unsecured Promissory Note Sixteen [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 6,000

Maturity date

Mar. 01, 2027

Interest rate

6%

Debt instrument, face value

211

Unsecured Promissory Note Seventeen [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 50,000

Maturity date

Mar. 01, 2027

Interest rate

6%

Debt instrument, face value

4,833

Unsecured Promissory Note Eighteen [Member] | Isiah Thomas III [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 4,500

Maturity date

Mar. 01, 2027

Interest rate

6%

Unsecured Promissory Note Nineteen [Member] | John McCabe Investments LLC [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 100,000

Maturity date

Mar. 01, 2027

Interest rate

8%

Unsecured Promissory Note Twenty [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 5,000

Maturity date

Mar. 01, 2027

Interest rate

6%

Accrued interest

507

Unsecured Promissory Note Twenty One [Member] | Isiah Thomas III [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 10,000

Maturity date

Mar. 01, 2027

Interest rate

6%

Unsecured Promissory Note Twenty Two [Member] | Isiah Thomas III [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 10,000

Maturity date

Mar. 01, 2027

Interest rate

6%

Unsecured Promissory Note Twenty Three [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 20,000

Interest rate

6%

Accrued interest

2,236

Unsecured Promissory Note Twenty Four [Member] | John McCabe Investments LLC [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 400,000

Maturity date

Mar. 01, 2027

Interest rate

8%

Unsecured Promissory Note Twenty Five [Member] | John McCabe Investments LLC [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 200,000

Maturity date

Mar. 01, 2027

Interest rate

8%

Unsecured Promissory Note Twenty Six [Member] | Dr.Kenneth Perego II [Member]

Short-Term Debt [Line Items]

Debt instrument, face value

$ 200,000

Maturity date

Mar. 01, 2027

Interest rate

8%

Accrued interest

$ 35,375

Notes Payable, Related Partie_2

Notes Payable, Related Parties (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Defined Benefit Plan Disclosure [Line Items]
Interest expense	$ 811,620	$ 177,169
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Interest expense	118,599	$ 58,804
Amortization of debt discounts	$ 5,978

Schedule of Notes Payable (Deta

Schedule of Notes Payable (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Less: unamortized debt discounts	$ 237,468	$ 24,136
Nonrelated Party [Member]
Short-Term Debt [Line Items]
Total notes payable	1,635,000	335,000
Less: unamortized debt discounts	237,468	24,136
Notes payable, net of discounts	1,397,532	310,864
Less: current maturities	1,397,532	310,864
Notes payable, long-term portion
Unsecured Promissory Note One [Member] | Nonrelated Party [Member]
Short-Term Debt [Line Items]
Total notes payable	1,300,000
Unsecured Promissory Note Two [Member] | Nonrelated Party [Member]
Short-Term Debt [Line Items]
Total notes payable	300,000
Unsecured Promissory Note Three [Member] | Nonrelated Party [Member]
Short-Term Debt [Line Items]
Total notes payable
Unsecured Promissory Note Four [Member] | Nonrelated Party [Member]
Short-Term Debt [Line Items]
Total notes payable	35,000	35,000
Unsecured Promissory Note Five [Member] | Nonrelated Party [Member]
Short-Term Debt [Line Items]
Total notes payable		$ 300,000

Schedule of Notes Payable (De_2

Schedule of Notes Payable (Details) (Parenthetical)					9 Months Ended
	Apr. 22, 2024 USD ($)	Apr. 19, 2024 USD ($) shares	Mar. 04, 2024 USD ($) shares	Jun. 23, 2023 USD ($) Integer shares	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Mar. 15, 2024	Aug. 18, 2023 USD ($)
Short-Term Debt [Line Items]
Debt interest rate							7%
Purchase price					$ 347,000	$ 62,000
Original issue discount					$ 434,289
Unsecured Promissory Note One [Member] | SDT Equities LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Sale of stock, percentage of ownership after transaction		12%
Debt instrument face amount		$ 1,300,000
Sale of stock consideration received		$ 1,196,000
Debt instrument maturity date		Jan. 19, 2025
Debt interest rate		12%
Shares issued | shares		8,666,667
Proceeds from issuance of warrants		$ 520,000
Debt discount amortized		351,638
Repayment of debt		360,000
Debt instrument, fee amount		257,446
Debt principal amount payment		207,000
Accrued interest		$ 50,446
Unsecured Promissory Note One [Member] | Sangnine Group L LC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt principal amount payment	$ 360,000
Unsecured Promissory Note Two [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Sale of stock, percentage of ownership after transaction		12%
Debt instrument face amount		$ 300,000
Sale of stock consideration received		$ 276,000
Debt instrument maturity date		Jan. 19, 2025
Debt interest rate		12%
Debt discount amortized		$ 80,185
Line of credit facility, commitment fee amount		$ 120,000
Commitment fee shares | shares		2,000,000
Unsecured Promissory Note Three [Member] | Sangnine Group L LC [Member]
Short-Term Debt [Line Items]
Debt instrument face amount			$ 300,000
Unsecured Promissory Note Three [Member] | Sangnine Group L LC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt instrument face amount			$ 360,000
Debt instrument maturity date			Sep. 04, 2024
Debt interest rate			15%
Debt discount amortized			$ 73,454
Accrued interest	3,300
Purchase price			300,000
Original issue discount			60,000
Legal fees			$ 15,000
Number of stock issued for commitment fee | shares			2,500,000
Unsecured Promissory Note [Member] | Sangnine Group L LC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt payment total	$ 363,300
Unsecured Promissory Note Four [Member] | L D L 8 Consulting L L C [Member]
Short-Term Debt [Line Items]
Debt instrument face amount								$ 35,000
Debt interest rate								10%
Increase in interest rate								15%
Unsecured Promissory Note Five [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt instrument face amount				$ 300,000
Debt instrument maturity date				Mar. 23, 2024
Debt interest rate				12%
Debt discount amortized				$ 42,175
Purchase price				276,000
Original issue discount				24,000
Legal fees				$ 7,500
Number of stock issued for commitment fee | shares				1,666,667
Net proceeds				$ 262,500
Brokerage fees				$ 6,000
Trading days | Integer				10
Debt instrument commitment fee paid				$ 100,000

Schedule of Notes Payable Debt

Schedule of Notes Payable Debt Discounts (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Short-Term Debt [Line Items]
Total debt discounts	$ 736,776	$ 79,675
Unamortized debt discounts	434,289
Notes Payable [Member]
Short-Term Debt [Line Items]
Fair value of commitment shares of common stock	163,477	42,175
Fair value of pre-funded warrants	351,638
Original issue discounts	188,000	24,000
Legal and brokerage fees	43,500	13,500
Total debt discounts	746,615	79,675
Amortization of debt discounts	505,286	26,233
Unamortized debt discounts	$ 241,329	$ 53,442

Schedule of Interest Expenses (

Schedule of Interest Expenses (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Notes Payable
Interest on convertible notes, related party	$ 15,123	$ 44,877
Interest on notes payable, related parties	112,621	58,804
Interest on notes payable	103,446	47,255
Amended warrants	51,008
Amortization of debt discounts, related parties	5,978
Amortization of debt discounts, common stock	134,049	12,684
Amortization of debt discounts, warrants	209,703
Amortization of debt discounts	179,692	13,549
Total interest expense	$ 811,620	$ 177,169

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Short-Term Debt [Line Items]
Amortization of debt discount	$ 736,776		$ 79,675
Common stock percentage	4.99%
Interest expenses of convertible note	$ 15,123	$ 44,877
Notes Payable [Member]
Short-Term Debt [Line Items]
Interest expenses of convertible note	103,446	47,255
Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Finance expense	$ 523,444	$ 26,233

Convertible Preferred Stock (De

Convertible Preferred Stock (Details Narrative)			3 Months Ended		9 Months Ended
	Jul. 25, 2024 USD ($) $ / shares shares	Jul. 03, 2024 USD ($) shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Sep. 17, 2024 $ / shares shares	Apr. 19, 2024 USD ($) $ / shares	Dec. 31, 2023 $ / shares shares
Preferred stock, shares authorized			9,200,000		9,200,000				9,200,000
Dividend rate percentage					6%
Warrants shares			24,178,317		24,178,317
Warrants exercise price per share | $ / shares			$ 0.18		$ 0.18
Preferred stock dividend recognized | $			$ 15,083	$ 15,083	$ 44,915	$ 43,808
Warrant [Member]
Warrants term							3 years
Warrants shares							1,500,000
Warrants exercise price per share | $ / shares							$ 0.25
Warrants outstanding | $	$ 40,873							$ 554,862
Warrant [Member] | Measurement Input, Price Volatility [Member]
Weighted average call option	1.52						168	146
Warrant [Member] | Measurement Input, Share Price [Member]
Weighted average call option | $ / shares	0.0272						0.0147	0.0640
Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized			10,000,000		10,000,000
Preferred stock, par value | $ / shares			$ 0.001		$ 0.001				$ 0.001
Preferred stock shares designated | $ / shares			$ 500,000		$ 500,000
Conversion of preferred stock into common stock, description					The shares of Series A Preferred Stock and Series B Preferred Stock are each currently convertible into one hundred (100) shares of the Company’s common stock. The Series A Preferred Stock accrues dividends at the rate of 6% per annum, payable in cash as and when declared by the Board or upon a liquidation
Dividend rate percentage					6%
Series A convertible preferred stock, issued			114,733		114,733				114,733
Series A convertible preferred stock, outstanding			114,733		114,733				114,733
Series B Convertible Preferred Stock [Member]
Preferred stock, par value | $ / shares			$ 0.001		$ 0.001				$ 0.001
Preferred stock shares designated | $ / shares			$ 600,000		$ 600,000
Series A convertible preferred stock, issued			238,501		238,501				238,501
Series A convertible preferred stock, outstanding			238,501		238,501				238,501
Series A Preferred Stock [Member]
Preferred stock, par value | $ / shares			$ 10		$ 10
Series A convertible preferred stock, issued			114,733		114,733
Series A convertible preferred stock, outstanding			114,733		114,733
Proceeds from sale of units | $	$ 150,000
Sale of units	15,000
Common stock sold for cash, shares	15,000
Warrants term	5 years
Warrants shares	1,500,000
Warrants exercise price per share | $ / shares	$ 0.25
Forfeited shares of series A preferred stock		4,500
Fair value of preferred stock | $		$ 45,000
Dividend preferred stock | $					$ 241,649
Series A Preferred Stock [Member] | Warrant [Member]
Warrants outstanding | $	$ 40,873
Series A Preferred Stock [Member] | Warrant [Member] | Measurement Input, Price Volatility [Member]
Weighted average call option	152
Series A Preferred Stock [Member] | Warrant [Member] | Measurement Input, Share Price [Member]
Weighted average call option | $ / shares	0.0272
Series B Preferred Stock [Member]
Preferred stock, par value | $ / shares			$ 15		$ 15
Series A convertible preferred stock, issued			238,501		238,501
Series A convertible preferred stock, outstanding			238,501		238,501

Schedule of Debt Commitments an

Schedule of Debt Commitments and Contingencies (Details) - USD ($)		Apr. 19, 2024	Apr. 19, 2023
SDT Equities Note [Member]
Short-Term Debt [Line Items]
Shares, Issued	[1]	8,666,667
SDT Equities Note - Commitment amounts	[1]	$ 520,000
Fourth AJB Note [Member]
Short-Term Debt [Line Items]
Fourth AJB Note - Commitment shares or warrants		2,000,000
Fourth AJB Note - Commitment amounts		$ 120,000
Third AJB Note [Member]
Short-Term Debt [Line Items]
Third AJB Note - Commitment shares or warrants		1,666,667
Third AJB Note - Commitment amounts			$ 100,000
[1]If, as of the date of the delivery by Holder of the Sale Reconciliation Notice, the Holder has not realized net proceeds from the sale of such Warrant Shares equal to at least the $ 520,000

Schedule of Debt Commitments _2

Schedule of Debt Commitments and Contingencies (Details) (Parenthetical)	Apr. 19, 2024 USD ($)
SDT Equities Note [Member]
Short-Term Debt [Line Items]
SDT Equities Note - Commitment amounts	$ 520,000	[1]
[1]If, as of the date of the delivery by Holder of the Sale Reconciliation Notice, the Holder has not realized net proceeds from the sale of such Warrant Shares equal to at least the $ 520,000

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($)		9 Months Ended
	Sep. 01, 2022	Sep. 30, 2023
Aggregate number common stock sold for cash		$ 300,000
Common Stock [Member]
Aggregate number common stock sold for cash		$ 3,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member]
Aggregate number common stock sold for cash	$ 10,000,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member] | Common Stock [Member]
Common stock, conversion basis	The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice

Schedule of Consideration For R

Schedule of Consideration For Related Party Debt (Details) - USD ($)				3 Months Ended		9 Months Ended
	Jul. 01, 2024	May 10, 2024	Mar. 15, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended			$ 2,193,981
Shares			10,971,000
Fair value			$ 724,086
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares			6,500,000
Fair value			$ 429,000
Common stock issued for services, shares	200,000	1,250,000	6,500,000	1,560,651	1,000,000	10,341,952	2,500,000
Isiah Thomas III [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended			$ 27,467
Shares			138,000
Fair value			$ 9,108
Isiah Thomas III [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares			2,000,000
Fair value			$ 132,000
Common stock issued for services, shares			2,000,000
Dr.Kenneth Perego II [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended			$ 337,000
Shares			1,685,000
Fair value			$ 111,210
Dr.Kenneth Perego II [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares			2,000,000
Fair value			$ 132,000
Common stock issued for services, shares			2,000,000
Mr Joerg Sommer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended			$ 26,116
Shares			131,000
Fair value			$ 8,646
Mr Joerg Sommer [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares			500,000
Fair value			$ 33,000
Common stock issued for services, shares			500,000
Dr John McCabe [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate debts extended			$ 1,803,398
Shares			9,017,000
Fair value			$ 595,122
Terry Buffalo [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares			2,000,000
Fair value			$ 132,000
Common stock issued for services, shares			2,000,000

Changes in Stockholders_ Equi_3

Changes in Stockholders’ Equity (Details Narrative) - USD ($)											3 Months Ended		9 Months Ended
	Sep. 25, 2024	Jul. 01, 2024	Jun. 30, 2024	May 10, 2024	Apr. 19, 2024	Mar. 31, 2024	Mar. 19, 2024	Mar. 15, 2024	Mar. 04, 2024	Feb. 09, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized											1,000,000,000		1,000,000,000		1,000,000,000
Common stock, par value											$ 0.001		$ 0.001		$ 0.001
Common stock, shares issued											105,890,570		105,890,570		79,827,618
Common stock, shares outstanding											105,890,570		105,890,570		79,827,618
Common stock shares issued for services, value											$ 43,921	$ 84,000	$ 624,725	$ 173,850
Common stock sold for cash														300,000
Additional collateral, aggregate fair value								$ 724,086
Investment maturity date								Mar. 01, 2027
Interest rate								10%
Debt interest rate								7%
Amortization of common stock options issued for services													$ 11,597	$ 121,052
Promissory Note [Member] | Mr Joerg Sommer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares							250,000
Common stock sold for cash							$ 9,839
Promissory Note [Member] | AJB Capital Investments LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares					2,000,000
Common stock shares issued for services, value					$ 80,185
Promissory Note [Member] | Sanguine Group Llc [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares									2,500,000
Common stock shares issued for services, value									$ 73,454
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock sold for cash, shares									10,394,610					3,000,000
Common stock issued for services, shares		200,000		1,250,000				6,500,000			1,560,651	1,000,000	10,341,952	2,500,000
Common stock shares issued for services, value		$ 9,000		$ 76,250							$ 1,561	$ 1,000	$ 10,342	$ 2,500
Common stock sold for cash														$ 3,000
Common Stock [Member] | Chief Financial Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock sold for cash, shares	600,000
Common stock sold for cash	$ 15,000
Common Stock [Member] | Todd Peterson [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock sold for cash, shares		250,000
Common stock sold for cash		$ 11,250
Fair value of shares		11,250
Common Stock [Member] | Officers and Directors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock sold for cash								$ 429,000
Common Stock [Member] | ClearThink Capital Partners LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock sold for cash, shares			231,840										278,811
Common stock issued for services, shares						381,680				149,621
Common stock shares issued for services, value						$ 24,695				$ 5,386
Common stock sold for cash			$ 12,473										$ 8,671
Common Stock [Member] | Two Consultants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued for services, shares								500,000
Common stock shares issued for services, value								$ 33,000

Common Stock Options (Details N

Common Stock Options (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Feb. 12, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average strike price	$ 0.14
Weighted average life	6 years 5 months 26 days
Stock-based compensation	$ 11,597	$ 121,052
Unamortized debt issuance expense	$ 141,935
2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares	10,892,000
Board of Directors [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of common stock			10,000,000
Officers Directors and Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unamortized debt issuance expense	$ 17,941

Warrants (Details Narrative)

Warrants (Details Narrative)					9 Months Ended
	Sep. 17, 2024 USD ($) $ / shares shares	Jul. 25, 2024 USD ($) $ / shares shares	Apr. 19, 2024 USD ($) $ / shares shares	Mar. 04, 2024 shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) shares
Warrants shares | shares					24,178,317
Exercise price per share | $ / shares					$ 0.18
Weighted average term					5 years 1 month 6 days
Interest expense					$ 811,620	$ 177,169
Fair value of warrants					51,008
Finance expense					209,704
Unamortized expenses					$ 141,935
Series A Preferred Stock [Member]
Warrants shares | shares		1,500,000
Exercise price per share | $ / shares		$ 0.25
Warrants term		5 years
Proceeds from sale of units		$ 150,000
Sale of units | shares		15,000
Common stock sold for cash, shares | shares		15,000
Warrant [Member]
Warrants shares | shares	1,500,000
Exercise price per share | $ / shares	$ 0.25
Warrants term	3 years
Warrants shares | shares	2,000,000
Share price | $ / shares	$ 0.50
Interest expense	$ 51,008
Warrants outstanding		$ 40,873	$ 554,862
Fair value of warrants			351,638
Warrant [Member] | SDT Equities LLC [Member]
Debt instrument, face amount			1,300,000
Proceeds from warrants			520,000
Warrant [Member] | SDT Equities LLC [Member] | Securities Purchase Agreement [Member]
Sale of stock consideration received			$ 1,175,500
Warrant [Member] | Series A Preferred Stock [Member]
Warrants outstanding		$ 40,873
Warrant [Member] | Measurement Input, Price Volatility [Member]
Weighted average call option	168	1.52	146
Warrant [Member] | Measurement Input, Price Volatility [Member] | Series A Preferred Stock [Member]
Weighted average call option		152
Warrant [Member] | Measurement Input, Share Price [Member]
Weighted average call option | $ / shares	0.0147	0.0272	0.0640
Warrant [Member] | Measurement Input, Share Price [Member] | Series A Preferred Stock [Member]
Weighted average call option | $ / shares		0.0272
Prefunded Warrant [Member] | SDT Equities LLC [Member]
Prefunded warrant | shares			8,666,667
Common Stock [Member]
Common stock sold for cash, shares | shares				10,394,610		3,000,000
Common Stock [Member] | SDT Equities LLC [Member]
Exercise price per share | $ / shares			$ 0.00001

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	9 Months Ended
	Sep. 30, 2024 USD ($)
Income Tax Disclosure [Abstract]
Federal net operating losses	$ 11,388,000
Net operating loss carry forwards expiration	The net operating loss carry forwards, if not utilized, will begin to expire in 2025.

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Nov. 08, 2024	Oct. 15, 2024	Oct. 10, 2024	Sep. 30, 2024	Dec. 31, 2023
Subsequent Event [Line Items]
Common stock, shares authorized				1,000,000,000	1,000,000,000
Preferred stock, par value				$ 0.001	$ 0.001
Shares issued				0	0
Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock, shares authorized		1,000,000,000
Subsequent Event [Member] | Series C Preferred Stock [Member] | Thomas Agreement [Member]
Subsequent Event [Line Items]
Shares issued	100
Accrued salaries	$ 486,512
Subsequent Event [Member] | Series C Preferred Stock [Member] | Preferred Stock [Member]
Subsequent Event [Line Items]
Preferred stock, par value			$ 0.001